-
Start Preamble
Start Printed Page 49649
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for five new animal drug applications (NADAs) from Fort Dodge Animal Health, Division of Wyeth Holdings Corp., a wholly owned subsidiary of Pfizer, Inc., to Boehringer Ingelheim Vetmedica, Inc.
DATES:
This rule is effective August 11, 2011.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, e-mail: steven.vaughn@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Fort Dodge Animal Health, Division of Wyeth Holdings Corp., a wholly owned subsidiary of Pfizer, Inc., 235 East 42d St., New York, NY 10017 has informed FDA that it has transferred ownership of, and all rights and interest in, five approved NADAs (NADAs 055-012, 055-018, 055-039, 065-071, and 065-440) to Boehringer Ingelheim Vetmedica, Inc., 2621 North Belt Highway, St. Joseph, MO 64506-2002. Accordingly, the Agency is amending the regulations in 21 CFR part 520 to reflect the transfer of ownership.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 520
- Animal drugs
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows:
Start PartPART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 520 continues to read as follows:
End Amendment Part Start Amendment Part2. Revise § 520.445 to read as follows:
End Amendment PartChlortetracycline and sulfamethazine powder.(a) Specifications. Each pound of soluble powder contains chlortetracycline bisulfate equivalent to 102.4 grams (g) of chlortetracycline hydrochloride and sulfamethazine bisulfate equivalent to 102.4 g of sulfamethazine.
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
(c) Related tolerances. See §§ 556.150 and 556.670 of this chapter.
(d) Conditions of use in swine. Administer in drinking water as follows:
(1) Amount. 250 milligrams (mg) of chlortetracycline and 250 mg of sulfamethazine per gallon.
(2) Indications for use. For the prevention and treatment of bacterial enteritis; as an aid in the reduction of the incidence of cervical abscesses; and as an aid in the maintenance of weight gains in the presence of bacterial enteritis and atrophic rhinitis.
(3) Limitations. Use as the sole source of chlortetracycline and sulfonamide. Not to be used for more than 28 consecutive days. Withdraw 15 days before slaughter.
[Removed]3. Remove § 520.445a.
End Amendment Part[Redesignated as § 520.441]4. Redesignate § 520.445b as § 520.441.
End Amendment Part Start Amendment Part5. Amend newly redesignated § 520.441 by revising paragraphs (b)(2), (b)(3), and the last sentence of paragraph (d)(4)(iii)(C) to read as follows:
End Amendment PartChlortetracycline powder.* * * * *(b) * * *
(2) Nos. 046573 and 000010 for use as in paragraph (d) of this section.
(3) No. 000010 for use as in paragraphs (d)(4)(i)(A), (d)(4)(i)(B), and (d)(4)(ii) through (d)(4)(iv) of this section.
* * * * *(d) * * *
(4) * * *
(iii) * * *
(C) * * * For Nos. 000010 and 021930, do not slaughter animals for food within 5 days of treatment. For No. 000010, do not slaughter animals for food within 24 hours of treatment.
* * * * *[Redesignated as § 520.443]6. Redesignate § 520.445c as § 520.443.
End Amendment Part Start Amendment Part7. Amend newly redesignated § 520.443 as follows:
End Amendment Part Start Amendment Parta. Revise paragraphs (a) and (b);
End Amendment Part Start Amendment Partb. Remove paragraph (d);
End Amendment Part Start Amendment Partc. Redesignate paragraph (e) as paragraph (d); and
End Amendment Part Start Amendment Partd. Revise the heading for newly redesignated paragraph (d) introductory text.
End Amendment PartThe revisions read as follows:
Chlortetracycline tablets and boluses.(a) Specifications. Each tablet/bolus contains 25, 250, or 500 milligrams (mg) chlortetracycline hydrochloride.
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
* * * * *(d) Conditions of use in calves—* * *
* * * * *Dated: August 4, 2011.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 2011-20404 Filed 8-10-11; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 8/11/2011
- Published:
- 08/11/2011
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2011-20404
- Dates:
- This rule is effective August 11, 2011.
- Pages:
- 49649-49649 (1 pages)
- Docket Numbers:
- Docket No. FDA-2011-N-0003
- Topics:
- Animal drugs
- PDF File:
- 2011-20404.pdf
- Supporting Documents:
- » Freedom of Information Summary NADA 141-324 Phenylpropanolamine
- » Freedom of Information Summary NADA 141-331 Pergolide
- » Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel
- » Freedom of Information Summary NADA 095-735 - Monensin
- » Freedom of Information Summary NADA 141-207 - Danofloxacin
- » Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate
- » Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate
- » reedom of Information Summary NADA 141-203 Deracoxib
- » Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary
- » Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin)
- CFR: (6)
- 21 CFR 520.441
- 21 CFR 520.443
- 21 CFR 520.445
- 21 CFR 520.445a
- 21 CFR 520.445b
- More ...